Iruma, Japan

Yukio Hoshino


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator in Immunosuppressive Agents: The Contributions of Yukio Hoshino

Introduction: Yukio Hoshino, based in Iruma, Japan, is a noteworthy inventor in the field of pharmacology. With a patent under his name focusing on 2-aminopropane-1,3-diol compounds, Hoshino's contributions have significant implications for immunosuppressive therapies, particularly in the context of organ transplants and autoimmune diseases.

Latest Patents: Hoshino holds a patent for a compound described as 2-aminopropane-1,3-diol, which is noteworthy for its medicinal applications. This compound exhibits superior immunosuppressive action with reduced toxicity, marking it as a safe option for use in pharmaceuticals aimed at preventing organ rejection and treating various autoimmune and allergic diseases. The patent details the general formulation of the compound, including variations that utilize protected amino groups or hydroxy groups, thereby expanding its potential applications in drug development.

Career Highlights: Hoshino is currently associated with Mitsubishi Pharma Corporation, a prominent player in the pharmaceutical industry. His work there has contributed to advancements in drug formulations and therapeutic methods, specifically targeting challenges faced in transplant medicine and immunology.

Collaborations: Throughout his career, Yukio Hoshino has collaborated with notable colleagues, including Kunitomo Adachi and Yoshiyuki Aoki. These partnerships have fostered innovation and growth within their research endeavors, combining expertise to enhance the therapeutic effectiveness of new pharmaceuticals.

Conclusion: Yukio Hoshino's inventive contributions to immunosuppressive agents represent a remarkable achievement within the pharmaceutical field. His patented work has laid the foundation for future advancements in treating complex medical conditions while ensuring patient safety. As research continues, his innovations will likely play a critical role in shaping the future of immunology and transplant medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…